Target intelligence / Profile preview

Solute carrier family 25 member 15 pseudogene 2 (SLC25A15P2)

Target
SLC25A15P2
Molecular classification
Pseudogene, Processed pseudogene
01

Overview

Solute carrier family 25 member 15 pseudogene 2 (SLC25A15P2) is a pseudogene, meaning it is a DNA sequence resembling a functional gene but is generally considered non-functional due to mutations that prevent normal gene expression or protein production[1][3]. SLC25A15P2 specifically resembles the SLC25A15 gene, which encodes a mitochondrial ornithine transporter; however, as a pseudogene, SLC25A15P2 typically does not encode a functional protein[1][3]. Pseudogenes like SLC25A15P2 may sometimes have regulatory effects at the RNA level, but there is no evidence this particular pseudogene acts as a conventional therapeutic target or has direct disease involvement, nor is it associated with any drug interactions or clinical biomarker utility[7]. The existence of processed pseudogenes is mainly a consequence of retrotransposon activity in the genome[2][7]. Key points: - SLC25A15P2 is not a protein-coding gene and is not considered a canonical drug target or receptor. - It is classified as a processed pseudogene and is not likely to play a direct role in disease or drug action[1][3][7]. - Entries regarding druggability, mechanism, or safety are not applicable, and providing structured target information should mark this entry as incorrect for therapeutic targeting purposes.

Other names
SLC25A15P2Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 pseudogene 2
02

Biological functions

Noncoding potentialPossible gene regulation by noncoding RNA
03

Disease associations

Other

Beyond the preview

Go deeper on Solute carrier family 25 member 15 pseudogene 2 (SLC25A15P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 15 pseudogene 2 (SLC25A15P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call